eMedicine Specialties > Pulmonology > Infectious Lung Diseases

Lung Abscess: Differential Diagnoses & Workup

Author: Nader Kamangar, MD, FACP, FCCP, FAASM,, Associate Professor of Clinical Medicine, Director of Hospitalist/Intensivist Program, Division of Pulmonary, Critical Care and Sleep Medicine, David Geffen School of Medicine at University of California Los Angeles; Associate Director, Combined Pulmonary and Critical Care Fellowship Program, Cedars-Sinai/Olive View-UCLA/West Los Angeles Veterans Affairs Medical Center
Coauthor(s): Curtis C Sather, MD, Fellow, Divison of Pulmonary/Critical Care Medicine, Cedars-Sinai Medical Center; Sat Sharma, MD, FRCPC, Professor and Head, Division of Pulmonary Medicine, Department of Internal Medicine, University of Manitoba; Site Director, Respiratory Medicine, St Boniface General Hospital
Contributor Information and Disclosures

Updated: Aug 19, 2009

Differential Diagnoses

Alcoholism
Pneumococcal Infections
Empyema, Pleuropulmonary
Pneumocystis Carinii Pneumonia
Hydatid Cysts
Pneumonia, Aspiration
Infective Endocarditis
Pneumonia, Bacterial
Lung Cancer, Non-Small Cell
Pneumonia, Fungal
Lung Cancer, Oat Cell (Small Cell)
Pulmonary Embolism
Mycetoma
Sarcoidosis
Mycobacterium Avium-Intracellulare
Thrombophlebitis, Septic
Mycobacterium Chelonae
Tuberculosis
Mycobacterium Kansasii
Wegener Granulomatosis
Nocardiosis

Other Problems to Be Considered

Cavitating lung cancer
Localized empyema
Infected bulla containing a fluid level
Infected congenital pulmonary lesion, such as bronchogenic cyst or sequestration
Pulmonary hematoma
Cavitating pneumoconiosis
Hiatus hernia
Lung parasites (eg, hydatid cyst, Paragonimus infection)
Actinomycosis
Wegener granulomatosis and other vasculitides
Cavitating lung infarcts
Cavitating sarcoidosis

Workup

Laboratory Studies

  • A complete white blood cell count with differential may reveal leukocytosis and a left shift.
  • Obtain sputum for Gram stain, culture, and sensitivity.
  • If tuberculosis is suspected, acid-fast bacilli stain and mycobacterial culture is requested.
  • Blood culture may be helpful in establishing the etiology.
  • Obtain sputum for ova and parasite whenever a parasitic cause for lung abscess is suspected.

Imaging Studies

  • Chest radiography7
    • A typical chest radiographic appearance of a lung abscess is an irregularly shaped cavity with an air-fluid level inside. Lung abscesses as a result of aspiration most frequently occur in the posterior segments of the upper lobes or the superior segments of the lower lobes.
    • The wall thickness of a lung abscess progresses from thick to thin and from ill-defined to well-circumscribed as the surrounding lung infection resolves. The cavity wall can be smooth or ragged but is less commonly nodular, which raises the possibility of cavitating carcinoma.
    • The extent of the air-fluid level within a lung abscess is often the same in posteroanterior or lateral views. The abscess may extend to the pleural surface, in which case it forms acute angles with the pleural surface.
    • Anaerobic infection may be suggested by cavitation within a dense segmental consolidation in the dependent lung zones.
    • Lung infection with a virulent organism results in more widespread tissue necrosis, which facilitates progression of underlying infection to pulmonary gangrene.
    • Up to one third of lung abscesses may be accompanied by an empyema.


Pneumococcal pneumonia complicated by lung necros...

Pneumococcal pneumonia complicated by lung necrosis and abscess formation.

Pneumococcal pneumonia complicated by lung necros...

Pneumococcal pneumonia complicated by lung necrosis and abscess formation.



A lateral chest radiograph shows air-fluid level ...

A lateral chest radiograph shows air-fluid level characteristic of lung abscess.

A lateral chest radiograph shows air-fluid level ...

A lateral chest radiograph shows air-fluid level characteristic of lung abscess.



A 54-year-old patient developed cough with foul-s...

A 54-year-old patient developed cough with foul-smelling sputum production. A chest radiograph shows lung abscess in the left lower lobe, superior segment.

A 54-year-old patient developed cough with foul-s...

A 54-year-old patient developed cough with foul-smelling sputum production. A chest radiograph shows lung abscess in the left lower lobe, superior segment.



A 42-year-old man developed fever and production ...

A 42-year-old man developed fever and production of foul-smelling sputum. He had a history of heavy alcohol use, and poor dentition was obvious on physical examination. Chest radiograph shows lung abscess in the posterior segment of the right upper lobe.

A 42-year-old man developed fever and production ...

A 42-year-old man developed fever and production of foul-smelling sputum. He had a history of heavy alcohol use, and poor dentition was obvious on physical examination. Chest radiograph shows lung abscess in the posterior segment of the right upper lobe.



Chest radiograph of a patient who had foul-smelli...

Chest radiograph of a patient who had foul-smelling and bad-tasting sputum, an almost diagnostic feature of anaerobic lung abscess.

Chest radiograph of a patient who had foul-smelli...

Chest radiograph of a patient who had foul-smelling and bad-tasting sputum, an almost diagnostic feature of anaerobic lung abscess.

  • Computed tomography7,8
    • CT scanning of the lungs may help visualize the anatomy better than chest radiography. CT scanning is very useful in the identification of concomitant empyema or lung infarction.
    • On CT scans, an abscess often is a rounded radiolucent lesion with a thick wall and ill-defined irregular margins.
    • The vessels and bronchi are not displaced by the lesion, as they are by an empyema.
    • The lung abscess is located within the parenchyma compared with loculated empyema, which may be difficult to distinguish on chest radiographs.
    • The lesion forms acute angles with the pleural surface chest wall.


A 42-year-old man developed fever and production ...

A 42-year-old man developed fever and production of foul-smelling sputum. He had a history of heavy alcohol use, and poor dentition was obvious on physical examination. Lung abscess in the posterior segment of the right upper lobe was demonstrated on chest radiograph (see Image 6). CT scan shows a thin-walled cavity with surrounding consolidation.

A 42-year-old man developed fever and production ...

A 42-year-old man developed fever and production of foul-smelling sputum. He had a history of heavy alcohol use, and poor dentition was obvious on physical examination. Lung abscess in the posterior segment of the right upper lobe was demonstrated on chest radiograph (see Image 6). CT scan shows a thin-walled cavity with surrounding consolidation.

  •  Ultrasonography
    • Peripheral lung abscesses with pleural contact or included inside a lung consolidation are detectable using lung ultrasonography at the bedside.
    • Lung abscess appears as a rounded hypoechoic lesion with an outer margin.
    • If a cavity is present, additional nondependent hyperechoic signs are generated by the gas-tissue interface.9

Procedures

Diagnostic material uncontaminated by bacteria colonizing the upper airway may be obtained for anaerobic culture from the following:

  • Blood culture
  • Pleural fluid (if empyema present)
  • Transtracheal aspirate
  • Transthoracic pulmonary aspirate
  • Surgical specimens
  • Fiberoptic bronchoscopy with protected brush  
  • Bronchoalveolar lavage with quantitative cultures
Expectorated sputum and other methods of sampling the upper airway do not yield useful results for anaerobic culture because the oral cavity is extensively colonized with anaerobes. Blood cultures are infrequently positive in patients with lung abscess, and empyema is rare.
 
The other modalities listed are invasive, costly, and require laboratory expertise. Bronchoscopy using a protected brush to obtain a specimen uncontaminated by the upper airway or quantitative culture of organisms from the bronchoalveolar lavage fluid has been advocated to establish bacteriologic diagnosis in lung abscess. However, the experience with this technique in diagnosis of anaerobic lung infections is limited and the diagnostic yield is uncertain. Perhaps most importantly, cultures obtained by any of these methods are unlikely to be positive after the initiation of antibiotics.10
 
Flexible fiberoptic bronchoscopy is performed to exclude bronchogenic carcinoma whenever bronchial obstruction is suspected.11

Histologic Findings

Lung abscesses begin as small zones of necrosis developing within the consolidated segments in pneumonia. These areas may coalesce to form single or multiple areas of suppuration, which are referred to as lung abscesses. If antibiotics interrupt the natural history at an early stage, the healing results in no residual changes. When the progressive inflammation erodes into the adjacent bronchi, the contents of the abscess are expectorated as malodorous sputum. Subsequently, fibrosis occurs, which causes a dense scar and separates the abscess. The abscess may still occur, and spillage of pus into the bronchial tree may disseminate the infection.

Histology of a lung abscess shows dense inflammat...

Histology of a lung abscess shows dense inflammatory reaction (low power).

Histology of a lung abscess shows dense inflammat...

Histology of a lung abscess shows dense inflammatory reaction (low power).



Histology of a lung abscess shows dense inflammat...

Histology of a lung abscess shows dense inflammatory reaction (high power).

Histology of a lung abscess shows dense inflammat...

Histology of a lung abscess shows dense inflammatory reaction (high power).

More on Lung Abscess

Overview: Lung Abscess
Differential Diagnoses & Workup: Lung Abscess
Treatment & Medication: Lung Abscess
Follow-up: Lung Abscess
Multimedia: Lung Abscess
References

References

  1. Bartlett JG, Finegold SM. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis. Jul 1974;110(1):56-77. [Medline].

  2. Wang JL, Chen KY, Fang CT, Hsueh PR, Yang PC, Chang SC. Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes. Clin Infect Dis. Apr 1 2005;40(7):915-22. [Medline].

  3. Mwandumba HC, Beeching NJ. Pyogenic lung infections: factors for predicting clinical outcome of lung abscess and thoracic empyema. Curr Opin Pulm Med. May 2000;6(3):234-9. [Medline].

  4. Pohlson EC, McNamara JJ, Char C, Kurata L. Lung abscess: a changing pattern of the disease. Am J Surg. Jul 1985;150(1):97-101. [Medline].

  5. Hirshberg B, Sklair-Levi M, Nir-Paz R, Ben-Sira L, Krivoruk V, Kramer MR. Factors predicting mortality of patients with lung abscess. Chest. Mar 1999;115(3):746-50. [Medline].

  6. Moreira Jda S, Camargo Jde J, Felicetti JC, Goldenfun PR, Moreira AL, Porto Nda S. Lung abscess: analysis of 252 consecutive cases diagnosed between 1968 and 2004. J Bras Pneumol. Mar-Apr 2006;32(2):136-43. [Medline].

  7. Stark DD, Federle MP, Goodman PC, Podrasky AE, Webb WR. Differentiating lung abscess and empyema: radiography and computed tomography. AJR Am J Roentgenol. Jul 1983;141(1):163-7. [Medline].

  8. Williford ME, Godwin JD. Computed tomography of lung abscess and empyema. Radiol Clin North Am. Sep 1983;21(3):575-83. [Medline].

  9. Bouhemad B, Zhang M, Lu Q, Rouby JJ. Clinical review: Bedside lung ultrasound in critical care practice. Crit Care. 2007;11(1):205. [Medline].

  10. Bartlett JG. Anaerobic bacterial infections of the lung. Chest. Jun 1987;91(6):901-9. [Medline].

  11. Sosenko A, Glassroth J. Fiberoptic bronchoscopy in the evaluation of lung abscesses. Chest. Apr 1985;87(4):489-94. [Medline].

  12. [Guideline] Tice AD, Rehm SJ, Dalovisio JR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis. Jun 15 2004;38(12):1651-72. [Medline].

  13. Appelbaum PC, Spangler SK, Jacobs MR. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers. Antimicrob Agents Chemother. Aug 1990;34(8):1546-50. [Medline].

  14. Perlino CA. Metronidazole vs clindamycin treatment of anerobic pulmonary infection. Failure of metronidazole therapy. Arch Intern Med. Oct 1981;141(11):1424-7. [Medline].

  15. Sanders CV, Hanna BJ, Lewis AC. Metronidazole in the treatment of anaerobic infections. Am Rev Respir Dis. Aug 1979;120(2):337-43. [Medline].

  16. Allewelt M, Schuler P, Bolcskei PL, Mauch H, Lode H. Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess. Clin Microbiol Infect. Feb 2004;10(2):163-70. [Medline].

  17. Ott SR, Allewelt M, Lorenz J, Reimnitz P, Lode H. Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess. Infection. Feb 2008;36(1):23-30. [Medline].

  18. Herth F, Ernst A, Becker HD. Endoscopic drainage of lung abscesses: technique and outcome. Chest. Apr 2005;127(4):1378-81. [Medline].

  19. Bandt PD, Blank N, Castellino RA. Needle diagnosis of pneumonitis. Value in high-risk patients. JAMA. Jun 19 1972;220(12):1578-80. [Medline].

  20. Bartlett JG. HIV infection and surgeons. Curr Probl Surg. Apr 1992;29(4):197-280. [Medline].

  21. Bartlett JG, Gorbach SL, Tally FP, Finegold SM. Bacteriology and treatment of primary lung abscess. Am Rev Respir Dis. May 1974;109(5):510-8. [Medline].

  22. Chung G, Goetz MB. Anaerobic Infections of the Lung. Curr Infect Dis Rep. Jun 2000;2(3):238-244. [Medline].

  23. Finegold SM, George WL, Mulligan ME. Anaerobic infections. Part II. Dis Mon. Nov 1985;31(11):1-97. [Medline].

  24. Finegold SM, Rolfe RD. Susceptibility testing of anaerobic bacteria. Diagn Microbiol Infect Dis. Mar 1983;1(1):33-40. [Medline].

  25. Howe C, Sampath A, Spotnitz M. The pseudomallei group: a review. J Infect Dis. Dec 1971;124(6):598-606. [Medline].

  26. La Scola B, Michel G, Raoult D. Isolation of Legionella pneumophila by centrifugation of shell vial cell cultures from multiple liver and lung abscesses. J Clin Microbiol. Mar 1999;37(3):785-7. [Medline].

  27. Mansharamani N, Balachandran D, Delaney D, Zibrak JD, Silvestri RC, Koziel H. Lung abscess in adults: clinical comparison of immunocompromised to non-immunocompromised patients. Respir Med. Mar 2002;96(3):178-85. [Medline].

  28. Mansharamani NG, Koziel H. Chronic lung sepsis: lung abscess, bronchiectasis, and empyema. Curr Opin Pulm Med. May 2003;9(3):181-5. [Medline].

  29. Narushima M, Suzuki H, Kasai T, et al. Pulmonary nocardiosis in a patient treated with corticosteroid therapy. Respirology. Mar 2002;7(1):87-9. [Medline].

  30. Senecal JL, St-Antoine P, Beliveau C. Legionella pneumophila lung abscess in a patient with systemic lupus erythematosus. Am J Med Sci. May 1987;293(5):309-14. [Medline].

  31. Weissberg D. Percutaneous drainage of lung abscess. J Thorac Cardiovasc Surg. Feb 1984;87(2):308-12. [Medline].

Further Reading

Keywords

lung abscess, lung abscesses, necrotizing pneumonia, lung gangrene, necrosis of pulmonary tissue, lung cavities, aspiration pneumonia, periodontal disease, bacteremia, tricuspid valve endocarditis

Contributor Information and Disclosures

Author

Nader Kamangar, MD, FACP, FCCP, FAASM,, Associate Professor of Clinical Medicine, Director of Hospitalist/Intensivist Program, Division of Pulmonary, Critical Care and Sleep Medicine, David Geffen School of Medicine at University of California Los Angeles; Associate Director, Combined Pulmonary and Critical Care Fellowship Program, Cedars-Sinai/Olive View-UCLA/West Los Angeles Veterans Affairs Medical Center
Nader Kamangar, MD, FACP, FCCP, FAASM, is a member of the following medical societies: American Academy of Sleep Medicine, American Association of Bronchology, American College of Chest Physicians, American College of Physicians, American Lung Association, American Medical Association, American Thoracic Society, California Thoracic Society, and Society of Critical Care Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Curtis C Sather, MD, Fellow, Divison of Pulmonary/Critical Care Medicine, Cedars-Sinai Medical Center
Curtis C Sather, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Medical Association, and American Thoracic Society
Disclosure: Nothing to disclose.

Sat Sharma, MD, FRCPC, Professor and Head, Division of Pulmonary Medicine, Department of Internal Medicine, University of Manitoba; Site Director, Respiratory Medicine, St Boniface General Hospital
Sat Sharma, MD, FRCPC is a member of the following medical societies: American Academy of Sleep Medicine, American College of Chest Physicians, American College of Physicians-American Society of Internal Medicine, American Thoracic Society, Canadian Medical Association, Royal College of Physicians and Surgeons of Canada, Royal Society of Medicine, Society of Critical Care Medicine, and World Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Stephen P Peters, MD, PhD, Professor, Department of Medicine, Wake Forest University
Stephen P Peters, MD, PhD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Association of Immunologists, American College of Chest Physicians, American College of Physicians, American Federation for Medical Research, American Thoracic Society, and Sigma Xi
Disclosure: See below for list of all activities None None

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

,, Kathy Roarty Placeholder
Disclosure: Nothing to disclose.

CME Editor

Timothy D Rice, MD, Associate Professor, Departments of Internal Medicine and Pediatrics and Adolescent Medicine, Saint Louis University School of Medicine
Timothy D Rice, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Physicians
Disclosure: Nothing to disclose.

Chief Editor

Zab Mosenifar, MD, Director, Division of Pulmonary and Critical Care Medicine, Director, Women's Guild Pulmonary Disease Institute, Executive Vice Chair, Department of Medicine, Cedars Sinai Medical Center; Professor of Medicine, David Geffen School of Medicine at UCLA
Zab Mosenifar, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Federation for Medical Research, and American Thoracic Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.